| Company/Division name | Cellares |
| Parent company | Cellares |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 350 |
| Year reshoring announced: | 2024 |
| Year reshoring implemented or to be implemented: | 2024 |
| Capital investment ($): | 255 |
| City reshored to: | Bridgewater |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell therapy |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Customization/Flexibility, Higher productivity, Lead time/Time to market |
